Skip to main content
LRMR logo
LRMR
(NASDAQ)
Larimar Therapeutics, Inc.
$3.47-- (--)
Loading... - Market loading

Larimar Therapeutics (LRMR) Stock Price & Financial Analysis

Larimar Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.44 - $3.64
52-Week High$6.42
52-Week Low$2.22
Open$3.45
Volume3.39M
Average Volume (3M)1.92M
Market Cap250.94M
Shares Outstanding72.95M
Price to Book (P/B)3.21
EV/EBITDA-1.00
50-Day MA$4.08
200-Day MA$3.99
52-Week Change16.13%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Larimar Therapeutics

What is the current stock price for LRMR?

As of the latest trading session, LRMR stock trades at $3.60. The 52-week range is $2.22–$6.42, with a day range of $3.44–$3.64.

What is the P/E ratio for LRMR?

The P/E ratio (Price-to-Earnings) for LRMR is shown in the Key Statistics section. This valuation metric helps compare Larimar Therapeutics, Inc. to industry peers.

Does LRMR pay dividends?

Larimar Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LRMR?

Based on 1 analyst, the consensus for LRMR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of LRMR?

Larimar Therapeutics's market capitalization is $262.6M, classifying it as a micro-cap company. Larimar Therapeutics operates in the Healthcare sector within the Biotechnology industry.